Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by senatoriceon Jan 16, 2011 9:37am

241 Views

Post# 17979772

RE: RE: RE: Johnson and Johnson

Did you ever think before your naval gazing post that SBM is making ground breaking progress here. Results speak for themselves.

Did you happen to talk to your(several) endocrinologists abouit the technology or science behind what SBM is doing.

This is not a pump. This is pure and simple science advancement. Believe it or not, science does advance.

Keep an eye on this and look in 6 months. Then we will see who is laughing.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading